Matteo Cameli
Matteo Cameli is an expert in Cardiology at University of Siena (Italy). As of October 2026, ScienceLeadR ranks Matteo Cameli in the top 1% of experts worldwide for Heart Failure. Matteo Cameli has authored 613 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 5 of them ongoing. SLR score: 2,384 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Public Health - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 613
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Impaired Left Atrial Function in Patients with Embolic Stroke of Undetermined Source. PMID 42881841 — stroke, atrial function, echocardiography, sex, embolic stroke, atrial function, left, embolic stroke of undetermined source | J Clin Med | 2026 | 0 |
| Beyond the 100-bpm Dogma: A Physiology-Guided Approach to Early Postoperative Heart Rate Management After Heart Transplantation. PMID 42834353 — adrenergic agents, physiology, stroke, heart rate, heart, heart transplantation, transplantation | Clin Transplant | 2026 | 0 |
| How to Do Echo in Left Ventricular Hypertrophy: A Consensus Statement of the Italian Society of Echocardiography and Cardiovascular Imaging. PMID 42781644 — hypertrophy, left ventricular, hypertrophy, cardiomyopathy, hypertrophic, echocardiography | J Cardiovasc Echogr | 2026 | 0 |
| Speckle-tracking staging of extra-valvular cardiac damage in degenerative mitral regurgitation: prognostic implications. PMID 42710014 — cardiovascular diseases, mitral valve insufficiency | J Cardiovasc Med (Hagerstown) | 2026 | 0 |
| Left atrial myopathy predicts cardiovascular outcome in hypertension and diabetes. PMID 42671700 — diabetes mellitus, muscular diseases, hypertension, diagnostic techniques, cardiovascular, prognosis, diabetes mellitus, type 2 | Int J Cardiovasc Imaging | 2026 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity 2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research | Phase 3 | Recruiting | 2026 |
| A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure 2024-514506-32-00 — heart failure, heart | Phase 3 | Not yet recruiting | 2025 |
| A randomized double blind placebo controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high risk primary prevention patients (VICTORION 1 PREVENT) 2022-502779-40-00 — cardiovascular diseases, primary prevention | Phase 3 | Active not recruiting | 2023 |
| Italian Anderson Fabry Disease Cardiovascular Registry NCT06806813 — registries, cardiovascular diseases, fabry disease | N/A | Recruiting | 2022 |
| Incidence and Echocardiographic Predictors of HFpEF in High Risk Population Afferent to Italian Echo labs Network NCT05753553 — incidence, heart failure, heart, heart failure, diastolic | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map